Article

DeepDrug: An Expert-led Domain-specific AI-Driven Drug-Repurposing Mechanism for Selecting the Lead Combination of Drugs for Alzheimer’s Disease

2024-07-07

Abstract excerpt

Alzheimer’s Disease (AD) significantly aggravates human dignity and quality of life. While newly approved amyloid immunotherapy has been reported, effective AD drugs remain to be identified. Here, we propose a novel AI-driven drug-repurposing method, DeepDrug, to identify a lead combination of approved drugs to treat AD patients. DeepDrug advances drug-repurposing methodology in four aspects. Firstly, it incorpora...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 2601bd32-82b4-5ef4-86c2-13c7de5b3178
DOI: 10.1101/2024.07.06.24309990

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

DeepDrug: An Expert-led Domain-specific AI-Driven Drug-Repurposing Mechanism for Selecting the Lead Combination of Drugs for Alzheimer’s DiseaseDOI 10.1101/2024.07.06.24309990Read

DeepDrug2: A Germline-focused Graph Neural Network Framework for Alzheimer’s Drug Repurposing Validated by Electronic Health RecordsSemantic proximity Read

Multi-Task Graph Neural Network For Alzheimer’s Disease Drug Repurposing Using Knowledge Graph And Multi-Level EvidenceSemantic proximity Read

Synthesize Heterogeneous Biological Knowledge via Representation Learning for Alzheimer’s Disease Drug RepurposingSemantic proximity Read

Novel graph attention autoencoder framework with multilayered validation identifies drug repurposing candidates for COVID-19 treatmentSemantic proximity Read

Multilayered validation of graph attention autoencoder–derived drug repurposing candidates for COVID-19Semantic proximity Read

DR3E-Net: Drug Repurposing Network Framework Based on Deep Embedding, Differentially Expressed Genes, and Drug Side EffectsSemantic proximity Read

Multi-layer guilt-by-association-based drug repurposing by integrating clinical knowledge on biological heterogeneous networksSemantic proximity Read

Artificial intelligence based computational framework for drug-target prioritization and inference of novel repositionable drugs for Alzheimer’s diseaseSemantic proximity Read

Identification of targets for drug repurposing to treat COVID-19 using a Deep Learning Neural NetworkSemantic proximity Read

Artificial intelligence for drug discovery and development in Alzheimer's diseaseSemantic proximity Read

Repurposing Non-pharmacological Interventions for Alzheimer’s Diseases through Link Prediction on Biomedical LiteratureSemantic proximity Read

Bridging the Computational-Experimental Gap: Leveraging Large Language Model to Prioritize Alzheimer’s Therapeutics Based on Comparison of Learning ModelsSemantic proximity Read